ingest
cdrApp
2017-07-06T11:54:34.012Z
082b3de9-6030-4a3e-a983-035a47fc699e
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2017-07-06T12:10:04.715Z
Setting exclusive relation
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2017-07-06T12:10:13.310Z
Setting exclusive relation
addDatastream
MD_TECHNICAL
fedoraAdmin
2017-07-06T12:10:13.811Z
Adding technical metadata derived by FITS
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2017-07-06T12:10:14.536Z
Setting exclusive relation
addDatastream
MD_FULL_TEXT
fedoraAdmin
2017-07-06T12:10:15.637Z
Adding full text metadata extracted by Apache Tika
modifyDatastreamByValue
RELS-EXT
fedoraAdmin
2017-07-06T12:10:24.844Z
Setting exclusive relation
modifyDatastreamByValue
RELS-EXT
cdrApp
2017-07-06T12:27:06.201Z
Setting exclusive relation
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-01-05T19:48:08.403Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-01-25T10:15:52.728Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-01-27T10:24:25.596Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-03-14T07:13:33.732Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-05-17T18:45:53.247Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-11T05:45:35.781Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-07-18T01:59:59.728Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-08-16T15:11:26.521Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-09-27T01:40:41.724Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2018-10-12T02:12:50.843Z
modifyDatastreamByValue
MD_DESCRIPTIVE
cdrApp
2019-03-20T20:30:00.546Z
Nicole
Tackmann
Author
Curriculum in Genetics and Molecular Biology
School of Medicine
IN VIVO DISCOVERIES IN MDM2-MEDIATED P53 REGULATION
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53.
Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation.
Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner.
We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
Spring 2017
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
Nicole
Tackmann
Author
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53.
Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation.
Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner.
We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
Spring 2017
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its
many target genes contribute to tumor suppression through regulation of cell cycle arrest,
senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53
regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53,
inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase
activity to facilitate p53 degradation. Upon cellular stress, upstream signaling
transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs)
bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic
overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also
transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and
RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression,
but whether these interactions are interdependent was unknown. We utilized mice bearing
the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with
mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found
that concomitant disruption of these signals enhanced tumorigenesis, indicating that
RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53
activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative
signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an
HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor
formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do
not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression
and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice
experience increased colorectal tumorigenesis and decreased p53 activation. Collectively,
these results suggest that RP-MDM2 interaction is important for transducing individual
oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of
MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using
mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that
MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC
overexpression and surprisingly that its disruption may provide a survival
advantage.
Spring 2017
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting
institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
Spring 2017
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017-05
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
2017-05
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
2017-05
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
2017-05
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
2017-05
University of North Carolina at Chapel Hill
Degree granting institution
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
2017-05
University of North Carolina at Chapel Hill
Degree granting institution
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Genetics and Molecular Biology
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
2017-05
Nicole
Tackmann
Creator
Curriculum in Genetics and Molecular Biology
School of Medicine
In Vivo Discoveries in MDM2-Mediated p53 Regulation
The transcription factor p53 is a stress sensor and tumor suppressor. Its many target genes contribute to tumor suppression through regulation of cell cycle arrest, senescence, apoptosis, and metabolism. Ubiquitously transcribed and translated, p53 regulation is primarily mediated through mouse double minute 2 (MDM2). MDM2 binds to p53, inhibits its transcriptional activation capabilities, and harbors E3 ubiquitin ligase activity to facilitate p53 degradation. Upon cellular stress, upstream signaling transducers modify or bind MDM2 to prevent its inhibition of p53. Ribosomal proteins (RPs) bind to MDM2 either in the response to ribosomal biogenesis stress or oncogenic overproduction of RPs, which occurs in cancer due to increased proliferation. p19ARF also transduces hyperproliferative signals, inhibiting MDM2 to stabilize p53. Both p19ARF- and RP-MDM2 binding are important for p53 activation following oncogenic c-MYC overexpression, but whether these interactions are interdependent was unknown. We utilized mice bearing the MDM2C305F mutation, which disrupts RPL11- and RPL5-MDM2 binding, crossed them with mice containing deletion of p19ARF, and examined c-MYC-induced tumorigenesis. We found that concomitant disruption of these signals enhanced tumorigenesis, indicating that RP-MDM2 and p19ARF-MDM2 binding are two distinct mechanisms causing c-MYC-induced p53 activation. Further, we examined whether RP-MDM2 interaction could transduce proliferative signals in cancers driven by other oncogenes. We crossed MDM2C305F mice to mice bearing an HrasG12V transgene or an ApcMin allele, which promote melanoma and colorectal tumor formation, respectively. We found that in response to RAS stimulation, RPL11 and RPL5 do not participate in MDM2 inhibition. In response to APC deletion, RPL11 and RPL5 expression and MDM2 binding are increased in a colon-specific manner. As a result, MDM2C305F mice experience increased colorectal tumorigenesis and decreased p53 activation. Collectively, these results suggest that RP-MDM2 interaction is important for transducing individual oncogenic stress signals in a p19ARF-independent manner. We have also examined the role of MDM2 E3 ligase activity in controlling p53 following the overexpression of c-MYC. Using mice bearing the MDM2Y487A mutation, which disrupts MDM2 E3 ligase activity, we found that MDM2 E3 ligase activity is dispensable for regulating p53 following oncogenic c-MYC overexpression and surprisingly that its disruption may provide a survival advantage.
2017
Molecular biology
Cellular biology
eng
Doctor of Philosophy
Dissertation
University of North Carolina at Chapel Hill Graduate School
Degree granting institution
Yanping
Zhang
Thesis advisor
Adrienne
Cox
Thesis advisor
Jeffrey
MacDonald
Thesis advisor
Karen
Mohlke
Thesis advisor
Qing
Zhang
Thesis advisor
text
2017-05
Tackmann_unc_0153D_16765.pdf
uuid:0177f3e2-fba7-4721-a444-015dd7a295f1
2019-07-06T00:00:00
proquest
2017-03-30T14:02:26Z
application/pdf
6627044
yes